1 Year Total Returns (Daily) Chart

View 1 Year Total Returns (Daily) for REVB.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View 1 Year Total Returns (Daily) Chart
Start Trial

Historical 1 Year Total Returns (Daily) Data

View and export this data back to 2021. Start Trial.
Date Value
September 08, 2026 -91.05%
September 04, 2026 -90.98%
September 03, 2026 -90.75%
September 02, 2026 -90.74%
September 01, 2026 -91.06%
August 31, 2026 -90.94%
August 28, 2026 -90.59%
August 27, 2026 -90.57%
August 26, 2026 -91.44%
August 25, 2026 -91.21%
August 24, 2026 -90.61%
August 21, 2026 -89.27%
August 20, 2026 -89.43%
August 19, 2026 -89.03%
August 18, 2026 -89.76%
August 17, 2026 -88.86%
August 14, 2026 -89.84%
August 13, 2026 -88.99%
August 12, 2026 -88.53%
August 11, 2026 -88.13%
August 10, 2026 -88.13%
August 07, 2026 -88.82%
August 06, 2026 -88.80%
August 05, 2026 -88.90%
August 04, 2026 -88.88%
Date Value
August 03, 2026 -89.55%
July 31, 2026 -90.46%
July 30, 2026 -89.84%
July 29, 2026 -89.85%
July 28, 2026 -90.35%
July 27, 2026 -90.80%
July 24, 2026 -91.28%
July 23, 2026 -91.34%
July 22, 2026 -90.57%
July 21, 2026 -90.60%
July 20, 2026 -90.17%
July 17, 2026 -89.61%
July 16, 2026 -90.49%
July 15, 2026 -90.51%
July 14, 2026 -90.55%
July 13, 2026 -91.16%
July 10, 2026 -91.15%
July 09, 2026 -91.45%
July 08, 2026 -90.36%
July 07, 2026 -90.41%
July 06, 2026 -88.82%
July 02, 2026 -88.31%
July 01, 2026 -89.43%
June 30, 2026 -88.56%
June 29, 2026 -88.58%

Total Return Definition

The Total return is the change in price over a specific period of time that includes dividends and distributions paid.

Read full definition.

1 Year Total Returns (Daily) Range, Past 5 Years

View 1 Year Total Returns (Daily) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

1 Year Total Returns (Daily) Benchmarks

View 1 Year Total Returns (Daily) Benchmarks
Start Trial
Shuttle Pharmaceuticals Holdings, Inc. -89.43%
ACADIA Pharmaceuticals, Inc. 8.63%
Agenus, Inc. 74.41%
Alnylam Pharmaceuticals, Inc. -42.84%
Amgen, Inc. 44.20%